• HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study - (12/05/23)
   
  
• The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants: a modelling study - (12/05/23)
   
  
• Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants - (12/04/23)
   
  
• CDC Reports Disparities in PrEP USE: 'particularly Black and Hispanic/Latino men and women.' - (12/04/23)
   
  
• The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants: a modelling study - (12/04/23)
   
  
• Considerations for long-acting antiretroviral therapy in older persons with HIV - (12/04/23)
   
  
More HIV Articles...
 

• HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
   
  
• AASLD: Epidemiological and Clinical Characteristics of HBV and HDV Co-infected Patients Followed by the Canadian HBV Network - (11/20/23)
   
  
• AASLD: A 5-YEAR SNAPSHOT OF NATIONAL DELTA HEPATITIS SCREENING IN METROPOLITAN FRANCE: DELTA DESCRIBE - DATA ISSUED FROM THE FRENCH HEALTH INSURANCE - (11/20/23)
   
  
More Hep D Articles...
 


---


 
Aging & Perinatally HIV Infected
 

• Ageism: the -ism affecting the lives of older people living with HIV - (11/29/23)
   
  
• AGE: High Rate of Metabolic Comorbidities in Young Adults With HIV Acquired Around Birth - (11/16/23)
   
  
More Aging & HIV Articles...
 


---


 
Mpox
 

• IAS: People living with HIV not more likely to be hospitalized with mpox unless immunosuppressed, finds WHO analysis - (07/25/23)
   
  
More Monkeypox Articles...
 

• Hepatitis C in Black Individuals in the USA Review - (12/05/23)
   
  
• AASLD: Total HCV patients treated with direct acting antivirals since 2014: Generics of Latest DAAs Are Key to Continuing Global Expansion of HCV Therapy - Mark Mascolini (11/29/23)
   
  
• AASLD: 100% SVR Rate in National Pediatric HCV Network for England-Wales-Ireland - Mark Mascolini (11/29/23)
   
  
• AASLD: Alcohol and Low Health Literacy Hamper Access to Curative Therapy for HCC - Mark Mascolini (11/29/23)
   
  
• AASLD: Early Read-Time Performance of the OraQuick®
  HCV Rapid Antibody Assay for the Exclusion of HCV Viremia - (11/21/23)
   
  
• AASLD: Successful Screening, Linkage to Care, and Treatment of Hepatitis C in a Tiny Shelter Encampment on Veterans Affairs Grounds - (11/21/23)
   
  
More Hep C Articles...
 

• HBV Patient Declaration of Rights -
   
  
• AASLD: Higher-Than-Expected Isolated Hep B Core Antibodies in Philadelphia Screening - Mark Mascolini (11/29/23)
   
  
• AASLD: Re-vaccination against hepatitis B in previous non-responders following hepatitis C eradication - Mark Mascolini (11/29/23)
   
  
• AASLD: Metabolomic profiling to predict histologic progression of liver fibrosis in patients with HIV and HBV coinfection: 20% have fibrosis progression in 3 years - Mark Mascolini (11/29/23)
   
  
• AASLD: HBV Vaccine Improves Survival With Liver Diseases Beyond HBV Infection - Mark Mascolini - (11/29/23)
   
  
More Hep B Articles...
 


---


 
Fatty Liver, NAFLD, NASH
 

• AASLD: Food Insecurity, Low Income Drive MASLD in US Adolescents - Mark Mascolini (11/29/23)
   
  
• AASLD: Fraction of Liver Injuries From Dietary Supplements Rising in US - Mark Mascolini (11/29/23)
   
  
More Fatty Liver Articles...
 

List not necessarily listed here in order of date being held.